Alere Q2 Revenues Fall 3 Percent | GenomeWeb

NEW YORK (GenomeWeb) – Alere reported today that its second quarter revenues decreased 3 percent year over year due in part to a negative foreign exchange impact, but grew between 3 and 4 percent on an organic basis. 

Total revenues for the three months ended June 30, 2015 were $629.2 million, compared to $647.4 million in the year-ago quarter, and beating the average Wall Street expectation of $625.2 million.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: variation patterns in wheat lines, regulatory variation in Capsella grandiflora, and more.

A Rockefeller University researcher is using edited ants to explore complex biological systems, the New York Times writes.

There's a heritable aspect to how much time people spend online, the Los Angeles Times reports.

Stat News reports that Joseph Gulfo is another contender for FDA commissioner.

Mar
02
Sponsored by
VelaDx

This online seminar will highlight recent advances in the use of next-generation sequencing to detect drug-resistant mutations in patients with HIV or HCV.